Zoom Logo

START Info Session Stage I - Shared screen with speaker view
Lenore Rasmussen
52:12
Does START funding help justifying supplemental Phase B funding (matching dollars)?
Maren Cattonar
53:09
Charlie, can we get a copy of these charts?
Alex Shulman
53:59
Does START assist with the initial SBIR application?
Brian Freeman
54:06
Could you comment on the eligibility of life science companies for the START program?
James Preisig
54:49
What are MassVentures “rights” with respect to companies that receive START grants at the different levels?
Carlos Castro-Gonzalez
54:53
What is the allowable use of funds under START? Is it mostly focused on business development activities versus R&D?
Kat Kuzmeskas
55:12
Does START take go-to-market timing into consideration for awarding the Grant? For example, certain bio-pharm products could take a few years to get to market. Does this affect ability to be selected this year?
pvicars
55:25
jeff bussgang had a great article on company valuations, your opening slide had a comment that Science technology companies are typical underfunded. what do we need to have to breakout even if we have exciting science and a potential customer base
Lenore Rasmussen
56:43
Are capital expenditures allowed in the START programs' funding?
Irving Sucholeiki
58:50
What are things that judges look for when evaluating management (what are negatives)?
James Preisig
59:12
We are actively pursuing additional government sources for aspects of our technology development. Our use of the START funding would depend on whih of these other sources come through. Is it acceptable (and not considered negative) to have different possible uses of the START funds based upon our success with these additional government funding source?
Melissa Corto
59:28
Similar question- what about K12 edtech? (IES SBIR)
Melissa Corto
01:00:41
ie similar question to deep tech
Akash Nandi
01:04:31
What is the timeline for the use of funds?
Melissa Corto
01:04:52
Great thanks!
James Preisig
01:06:36
I we are fortunate enough to win Phase I and are notified in late April, can we pre-spend funds out of our own capital then reimburse ourselves for those expenses once we received the START funds in June.
Maren Cattonar
01:07:25
Do the reviewers sign an NDA or confidentiality agreement with MassVentures?
Lynn Feldman
01:09:45
We got one four years ago that has been extended because Covid interfered with the clinical trial. Can that qualify?
Mehrdad Mehrvand
01:09:52
Can 30-50% of the start fund be used for a software license that is used for both R&D and business development?
ExtendBio - Laura
01:12:34
Just to confirm, the START funding is for the platform and company growth, not for the specific product that the SBIR was for?
sissi liu
01:15:15
I missed the first 15 min. is application similar to last years?
Matt Snow
01:16:42
thanks everyone for attending!